𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes

✍ Scribed by Tatsuo Fujie; Kouichirou Tahara; Fumiaki Tanaka; Masaki Mori; Kazutou Takesako; Tsuyoshi Akiyoshi

Publisher
John Wiley and Sons
Year
1999
Tongue
French
Weight
96 KB
Volume
80
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Identification of a SART-1-derived pepti
Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes
✍ Megumi Kikuchi; Masanobu Nakao; Yoshiko Inoue; Kazuko Matsunaga; Shigeki Shichij πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 126 KB

We have described the SART-1 gene-encoding peptides recognized by HLA-A2601-restricted and tumor-specific cytotoxic T lymphocytes (CTLs). We now have investigated whether SART-1 encodes peptides capable of inducing the HLA-A24-restricted CTLs. Among the 18 different peptides with HLA-A24-binding mot

Identification of HLA-A24 epitope peptid
Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte
✍ Ikuei Nukaya; Masazumi Yasumoto; Tomoko Iwasaki; Mitsuko Ideno; Alessandro Sette πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 135 KB

Carcinoembryonic antigen (CEA), which is expressed in several cancer types, is a potential target for specific immunotherapy. HLA-A24 is the most frequent allele among Japanese and is also frequently present in Asians and Caucasians. We tested CEA-encoded HLA-A24 binding peptides for their capacity

Two new tumor-specific antigenic peptide
Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2
✍ Wenbin Ma; Catherine Germeau; Nathalie Vigneron; Anne-Sophie Maernoudt; Sandra M πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 236 KB πŸ‘ 1 views

## Abstract We have identified 2 antigens recognized by several melanoma‐specific cytolytic T lymphocyte clones isolated from a melanoma patient with a clinical history of tumor regression after immunotherapy. Both antigens are presented by HLA‐A2 and encoded by gene __MAGE‐C2__, a cancer‐germline

A HER2/NEU-derived peptide, a Kd-restric
A HER2/NEU-derived peptide, a Kd-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8+ cytotoxic T lymphocytes
✍ Yasushi Ikuta; Toshiharu Okugawa; Reiko Furugen; Yasuhiro Nagata; Yoshiyuki Taka πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 125 KB πŸ‘ 2 views

We have identified an H-2K(d)-binding peptide, HER2p780 (PYVSRLLGI), derived from murine HER2/neu (HER2), that can induce HER2-specific murine cytotoxic T lymphocytes (CTL). Weekly vaccination of BALB/c mice by syngeneic dendritic cells pulsed with HER2p780 peptide, entirely common to murine and hum